NIH bias against African-Americans confirmed

NewsGuard 100/100 Score

Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.

The audit involved analysis of data from more than 40,000 researchers who submitted more than 80,000 grant applications to NIH between 2000 and 2006. It showed that only about 16 percent of those from black applicants were approved, compared with about 29 percent of those from white scientists.

Even when other factors like scientists’ education and training were taken into account, black applicants were still about 10 percentage points less likely than whites to get NIH funding, the researchers reported. About 27 percent of white applicants’ requests were successful, compared with only about 17 percent of blacks’. Asians applying for money appeared to be slightly less likely than whites to get grants, but that gap disappeared when the researchers matched equally qualified white and Asian U.S. citizens. Hispanics were about as successful as whites.

The findings are troubling because they indicate that race remains a significant factor in who gets funding for research into diabetes, cancer, heart disease and other health problems from the premier funder of biomedical research, the researchers said.

Donna K. Ginther, director of the University of Kansas Center of Science, Technology and Economic Policy, who led the study published in the journal Science said, “We have a very serious issue. Science needs to reflect the diversity and power and potential of the population.

NIH’s internal auditing had indicated that there might be a problem with bias in its scientific review process. The agency initiated and helped fund the study to investigate those concerns. Officials agreed the new findings were alarming and outlined steps the $31 billion agency will take to try to address the problem. “This situation is not acceptable,” NIH Director Francis S. Collins said. “This data is deeply troubling.”

For the study, Ginther and colleagues analyzed data collected by the NIH from all scientists with doctorates applying for the most common grants the agency hands out. The data included the applicants’ race and were combined with information garnered from other sources, including where researchers were educated, their training, whether they had applied for grants before and whether they served on NIH committees.

Only 1.4 percent of applications came from black scientists, even though they account for about 12 percent of the U.S. population, the researchers found. Moreover, the applications from black scientists tended to receive poorer scores than those from whites, resulting in bleaker chances of getting funded. “Our research says, ‘If you hold everything else constant and the only thing different between these two investigators is the color of their skin, that person is less likely to get funded,” Ginther said.

As uncomfortable as it makes us, we must acknowledge that the differences observed may reflect biases that are insidiously interwoven into the basic fabric of the merit/reward system of science,” NIH Director Francis Collins and Principal Deputy Director Lawrence Tabak wrote in a commentary on the study. “I was deeply dismayed,” Collins said. “This is simply unacceptable that there are differences in success that can't be explained”. While Collins believes that “flagrant, intentional racism is rare,” he said that “more subtle kinds of bias” - such as the reviewer inferring an applicant's race based on cues in the application - may be influencing grant decisions.

Raynard Kington, an African-American former NIH deputy director, now president of Grinnell College in Iowa, and last author of the study, said, “This shouldn't be news. What it should be is a wake-up call.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). NIH bias against African-Americans confirmed. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20110822/NIH-bias-against-African-Americans-confirmed.aspx.

  • MLA

    Mandal, Ananya. "NIH bias against African-Americans confirmed". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20110822/NIH-bias-against-African-Americans-confirmed.aspx>.

  • Chicago

    Mandal, Ananya. "NIH bias against African-Americans confirmed". News-Medical. https://www.news-medical.net/news/20110822/NIH-bias-against-African-Americans-confirmed.aspx. (accessed April 25, 2024).

  • Harvard

    Mandal, Ananya. 2018. NIH bias against African-Americans confirmed. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20110822/NIH-bias-against-African-Americans-confirmed.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer